Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Gyeyoung Choi"'
Publikováno v:
Mediators of Inflammation, Vol 2016 (2016)
The prevalence of allergic disorders including atopic dermatitis (AD) and food allergy (FA) has increased dramatically in pediatric populations, but there is no effective drug available for their management. Therefore, trials are required for the dev
Externí odkaz:
https://doaj.org/article/00f30916552c463aa131c63f34ab440b
Publikováno v:
International journal of environmental research and public health. 19(19)
Although chimeric antigen receptor (CAR) T-cell therapy has shown a high response rate in lymphoma patients, its cost-effectiveness is controversial due to the high price and uncertainty of the clinical evidence. In addition to the high acquisition c
Autor:
Miyoung Park, Kyoung-Mi Jung, Young-Ho Park, Yang Won Lee, Gyeyoung Choi, Nam Hyun-Jin, Beom Joon Kim, C.‐H. Won
Publikováno v:
British Journal of Dermatology. 180:1030-1038
Background Transient receptor potential vanilloid subfamily, member 1 (TRPV1) may play an important role in pruritus and inflammation induction in atopic dermatitis (AD). The treatment effect of TRPV1 antagonist via topical application in patients wi
Autor:
Ji-Hae Lee, Jae-Heon Kang, Jonghwa Roh, Kyoung-Mi Jung, Gyeyoung Choi, Hyun Woo Jeong, Wangi Kim, Nam Hyun-Jin
Publikováno v:
Food Supplements and Biomaterials for Health. 1
Autor:
Beom Joon Kim, Dong Hun Lee, Chong-Hyun Won, Kyoung-Mi Jung, Chang Ook Park, Miyoung Park, Bo Young Chung, Yang Won Lee, Kyu Han Kim, Young Ho Park, Hyun Jin Nam, Chun Wook Park, Gyeyoung Choi
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:1340-1347.e4
Asivatrep is a potent and selective antagonist of transient receptor potential vanilloid subfamily V member 1 (TRPV1), which plays an important role in itch and inflammation in atopic dermatitis (AD).This current study aimed to evaluate the efficacy
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 5; Pages: 2494
We sought to estimate the lifetime healthcare costs and outcomes associated with the exposure to the escalated concentration of fine particulate matter (particle size < 2.5 μm, PM2.5) among adult Korean women. We adapted a previously developed Marko
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 112
PAC-14028 (Asivatrep: C21H22F5N3O3S) cream is a novel, topical nonsteroidal, anti-inflammatory, and TRPV1 (transient receptor potential vanilloid subfamily, member 1) antagonist for the treatment of mild to moderate atopic dermatitis. Concerns about
Autor:
Myoung Hee Park, Nam Hyun-Jin, Gyeyoung Choi, Young-Ho Park, Bonglee Kim, Chong-Hyun Won, Kyoung-Mi Jung, Yang Won Lee
Publikováno v:
British Journal of Dermatology. 180
Autor:
Myoung Hee Park, Gyeyoung Choi, Chong-Hyun Won, Yang Won Lee, Nam Hyun-Jin, Young-Ho Park, Kyoung-Mi Jung, Bonglee Kim
Publikováno v:
British Journal of Dermatology. 180
Autor:
Kyung-Hwan Hwang, Myeong-Hun Yeom, Miyoung Park, Donghyun Kim, Il-Hong Bae, Jiwon Han, Gyeyoung Choi, Young-Ho Park, Chang Seok Lee
Publikováno v:
Experimental Dermatology. 23:819-824
Compound K (CK) is one of the major metabolites of ginsenosides exhibiting a variety of pharmacological properties such as anti-ageing, anti-oxidation and anti-inflammatory activities. However, the protective efficacy of CK in abnormal skin condition